StonvexLoading…
StonvexStonvexStonvexCore line items from AAT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $39.91M | $43.03M | $42.88M | $38.12M |
Operating Income | $145.93M | $129.20M | $121.75M | $114.73M |
Net Income | $3.15M | $8.98M | $10.48M | $9.63M |
EPS (Diluted) | $0.92 | $0.94 | $0.84 | $0.72 |
Total Assets | $2.92B | $3.27B | $2.98B | $2.99B |
Total Liabilities | $1.83B | $2.15B | $1.83B | $1.80B |
Cash & Equivalents | $129.36M | $425.66M | $82.89M | $49.57M |
Free Cash Flow OCF − CapEx | $94.86M | $136.90M | $105.77M | $65.29M |
Shares Outstanding | 61.39M | 61.14M | 60.90M | 60.72M |